Skip to main content
All lobbying filings

National Association of Chain Drug Stores

National Association of Chain Drug Stores filed a Q1 report for National Association of Chain Drug Stores on April 18, 2025.

Lobbying for National Association of Chain Drug Stores

As filed: NATIONAL ASSOCIATION OF CHAIN DRUG STORES for NATIONAL ASSOCIATION OF CHAIN DRUG STORES.

All filings by National Association of Chain Drug Stores · Everything National Association of Chain Drug Stores has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 18, 2025
Expenses
$360,000
What this organization spent lobbying with its own staff. Reported using IRS section 6033(b)(8) definitions (method B): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Virginia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3

H.R. 1770 Equitable Community Access to Pharmacist Services Act H.R. 2484 Seniors Access to Critical Medications Act S. 526 Pharmacy Benefit Manager (PBM) Transparency Act S. 527 Prescription Pricing for the People Act S. 882 Patients Before Middlemen (PBM) Act S. 927 Protecting Pharmacies in Medicaid Act S. 1404 Combating Organized Retail Crime Act S. 2477 Equitable Community Access to Pharmacist Services Act

H.R. 1770 Equitable Community Access to Pharmacist Services Act H.R. 2484 Seniors Access to Critical Medications Act S. 882 Patients Before Middlemen (PBM) Act S. 927 Protecting Pharmacies in Medicaid Act S. 2477 Equitable Community Access to Pharmacist Services Act

H.R. 1968 Full-Year Continuing Appropriations and Extensions Act of 2025

 Bills named in this filing 9
  • H.R. 1770
    Equitable Community Access to Pharmacist Services Act
  • H.R. 2484
    Seniors’ Access to Critical Medications Act of 2025
  • S. 526
    Pharmacy Benefit Manager Transparency Act of 2025
  • S. 527
    Prescription Pricing for the People Act of 2025
  • S. 882
    Patients Before Middlemen Act
  • S. 927
    Protecting Pharmacies in Medicaid Act
  • S. 1404
    Combating Organized Retail Crime Act
  • S. 2477
    Equitable Community Access to Pharmacist Services Act
  • H.R. 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem